Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v6-FR
Language English French
Date Updated 2017-12-02 2017-05-04
Drug Identification Number 02229519 02229519
Brand name MYLAN-GLICLAZIDE MYLAN-GLICLAZIDE
Common or Proper name Gliclazide Gliclazide
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients GLICLAZIDE GLICLAZIDE
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT, 60BL 100BT, 60BL
ATC code A10BB A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-12-01 2017-11-03
Actual start date
Estimated end date Unknown Unknown
Actual end date 2017-12-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments discontinued under ID 16126
Health Canada comments